Biobanks and Biomarker Research in Cardiovascular Disease

Journal of Cardiovascular Nursing

Volumn 23, Issue 2, 2008, Pages 153-158

  Frazier, Lorraine ^a   Sparks, Elizabeth ^b   Sanner, Jennifer E ^b   Henderson, Maria ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Biobanks; Cardiovascular disease; Genetics; Research

Indexed keywords

ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; GENETICS; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEALTH PERSONNEL ATTITUDE; HUMAN; HUMAN EXPERIMENT; NUCLEIC ACID DATABASE; NURSE ATTITUDE; NURSING; NURSING METHODOLOGY RESEARCH; NURSING RESEARCH; ORGANIZATION AND MANAGEMENT; REVIEW; STANDARD;

ATTITUDE OF HEALTH PERSONNEL; BIOLOGICAL SPECIMEN BANKS; CARDIOVASCULAR DISEASES; DATABASES, NUCLEIC ACID; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMAN EXPERIMENTATION; HUMANS; NURSE'S ROLE; NURSING METHODOLOGY RESEARCH; NURSING RESEARCH; QUALITY ASSURANCE, HEALTH CARE;

EID: 41849102051     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/01.JCN.0000305075.51399.1c     Document Type: Article

References (24)

1. Gelb BD. Recent advances in the understanding of genetic causes of congenital heart defects. Front Biosci. 2000;5:d321-d333.
2. Rodriguez-Viciana P, Tetsu O, Tidyman WE, et al. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science. 2006;311:1287-1290.
3. Andrews LB. Harnessing the benefits of biobanks. J Law Med Ethics. 2005;33:22-30.
4. Dushenes M, Salle C. Accountability in population biobanking: comparative approaches. J Law Med Ethics. 2005;33(1):40-53.
5. Willard HF. Overview of large population study issues and possible approaches. Updated March 2006. Accessed November 4, 2007.
6. Swede H, Stone CL, Norwood AR. National population-based biobanks for genetic research. Genet Med. 2007; 9:141-149.
7. Knoppers BM. Biobanking international norms. J Law Med Ethics. 1995;33(1):7-14.
8. McQuillan GM, Porter KS, Agelli M, Kington R. Consent for genetic research in a general population: the NHANES experience. Genet Med. 2003;5:35-42.
9. Sanner J, Frazier L. Factors that influence characteristics of genetic biobanks. J Nurs Scholarsh. 2007;39:25-29.
10. Frazier L, Calvin AO, Mudd GT, Cohen MZ. Understanding of genetics among older adults. J Prof Nurs. 2006;38:126-132.
11. National Office of Public Health Genomics. Center for Disease Control and Prevention. Accessed May 28, 2007.
12. Reamon-Buettner SM, Borlak J. Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease. J Med Genet. 2004;41:684-690.
13. Gelb BD. Recent advances in the understanding of genetic causes of congenital heart defects. Front Biosci. 2000;5:d321-d333.
14. Goldmuntz EB, Clark J, Mitchell LE, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol. 1998;32:492-498.
15. Johnson MR, Hing A, Wood MK, Watson MS. Chromosome abnormalities in congenital heart disease. Am J Med Genet. 1997;70:292-298.
16. Bruneau BG, Nemer G, Schmitt JP, et al. A murine model of Holt-Oram syndrome defines the roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell. 2001;106:709-721.
17. Kathiriya IS, Srivastava D. Left-right asymmetry and cardiac looping: implications for cardiac development and congenital heart disease. Am J Med Genet. 2000;97:271-279.
18. Ryan K, Chin AJ. T-box genes and cardiac development. Birth Defects Res. 2003;69:25-37.
19. Plageman TF, Yutzey KE. Differential expression and function of the Tbx5 and Tbx20 in cardiac development. J Biol Chem. 2004;279:19026-19034.
20. Arabi M, Majdalani M, Nemer G, et al. Molecular markers of congenital heart disease. Congenit Cardiol Today. 2007;5:1.
21. Weismann CG, Gelb BD. The genetics of congenital heart disease: a review of recent developments. Curr Opin Cardiol. 2007;22:200-206.
22. Kafka H, Johnson MR, Gatzoulis MA. The team approach to pregnancy and congenital heart disease. Cardiol Clin. 2006;24:587-605.
23. Reamon-Buettner SM, Borlak J. Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease. J Med Genet. 2004;41:684-690.
24. Moskowitz IP, Kim JB, Moore ML, et al. A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell. 2007;129:1365-1376.